- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 88 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- May 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- May 2023
- 201 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- March 2023
- 180 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 170 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2023
- 87 Pages
France
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP

The Short Read Sequencing market within the context of Molecular Diagnostics is a rapidly growing field. It is used to sequence the DNA of a sample, allowing for the identification of genetic mutations and other genetic information. This technology is used in a variety of applications, including cancer diagnostics, infectious disease diagnostics, and prenatal diagnostics. Short Read Sequencing is also used in research and drug development, as well as in the development of personalized medicine.
The Short Read Sequencing market is highly competitive, with a number of companies offering products and services. These include Illumina, Thermo Fisher Scientific, BGI, Oxford Nanopore Technologies, Pacific Biosciences, and QIAGEN. Show Less Read more